Document Detail

What is the Background Incidence of Malignancy in Children with Rheumatic Disease?
MedLine Citation:
PMID:  23378144     Owner:  NLM     Status:  In-Data-Review    
Until recently, relatively little was known about the background risk of malignancy in pediatric rheumatic diseases. Worrying reports about the development of malignancies in children treated with new biologic agents have prompted rigorous studies of the incidence of malignancy associated with juvenile idiopathic arthritis (JIA). These studies reveal that JIA is likely to be associated with an increased risk of incident malignancy, irrespective of treatment with new biologic agents. A preliminary study indicates that the background risk of malignancy is also elevated in pediatric-onset systemic lupus erythematosus. On the basis of simple observation, the background risk of malignancy among children with Sjögren syndrome and dermatomyositis seems much lower than the markedly elevated risk found in adults with the same diagnoses. Clearly, the background risk of malignancy must be considered in any evaluation of the safety of new therapeutic agents.
Melissa L Mannion; Timothy Beukelman
Related Documents :
21618364 - Maternal inflammatory bowel disease and offspring body size: a prospective cohort study.
24312064 - Social orienting of children with autism to facial expressions and speech: a study with...
22253394 - Survival without disability to age 5 years after neonatal caffeine therapy for apnea of...
24837704 - Systemic auto-antibodies in children with autism.
1970834 - Antihistamine- and decongestant-induced performance decrements.
20687204 - Etiologies of spontaneous pneumomediastinum in children in middle taiwan.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current rheumatology reports     Volume:  15     ISSN:  1534-6307     ISO Abbreviation:  Curr Rheumatol Rep     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-02-04     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100888970     Medline TA:  Curr Rheumatol Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  310     Citation Subset:  IM    
Department of Pediatrics, Division of Rheumatology, The University of Alabama at Birmingham, Children's Park Place 210, 1600 7th Ave South, Birmingham, AL, 35233, USA,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The Foker Technique (FT) and Kimura Advancement (KA) for the Treatment of Children with Long-Gap Eso...
Next Document:  The role of the microbiome in rheumatic diseases.